Discover and read the best of Twitter Threads about #qgen
Most recents (2)
NOVACYT
Good question.
#NCYT has been installing Q16s and Q32s weekly now in the NHS, so what they've done with the care home trial is expand it now to include the NHS hospitals.
#ALNOV #NVYTF #GDR #AVCT #N4P #FEVR #GSK #HCN #ABC #QGEN #DDDD #RMS
Good question.
#NCYT has been installing Q16s and Q32s weekly now in the NHS, so what they've done with the care home trial is expand it now to include the NHS hospitals.
#ALNOV #NVYTF #GDR #AVCT #N4P #FEVR #GSK #HCN #ABC #QGEN #DDDD #RMS
The care home Q16/Q32 trial held up to lab testing.
Excellent.
What happens if you go all-in, and get data from supply to hospital wards too?
Well if it can hold 99%, then you can approve rapid RT-qPCR machines as permanent installations across the entire NHS and social care
Excellent.
What happens if you go all-in, and get data from supply to hospital wards too?
Well if it can hold 99%, then you can approve rapid RT-qPCR machines as permanent installations across the entire NHS and social care
We obviously want our kit in there, but what we're suggesting is an entire rewrite of the UK's microbiology network.
That involves change at all levels of the NHS - a major public policy change too.
Nothing has been done on this scale in diagnostics in our generation.
That involves change at all levels of the NHS - a major public policy change too.
Nothing has been done on this scale in diagnostics in our generation.
I've written on Horizon Discovery #HZD before. I think this company may soon turn the corner into real operating leverage, then profitability.
Shares are dragging along the bottom and it's somewhere between 3-4x sales. If I'm right, this could be very cheap later on.
Thread:
Shares are dragging along the bottom and it's somewhere between 3-4x sales. If I'm right, this could be very cheap later on.
Thread:
Briefly the story so far.
#HZD is a life sciences company. Here is how they describe themselves:
"Global leader in the application of gene editing and gene modulation technologies"
These things sell expensive and they rebuffed a bid from Abcam in 2018.
#HZD is a life sciences company. Here is how they describe themselves:
"Global leader in the application of gene editing and gene modulation technologies"
These things sell expensive and they rebuffed a bid from Abcam in 2018.
Woodford had a stake in #HZD.
He's now gone. His holding - and more - was picked up by Valueact, who just got Merlin Ent's in the UK sold into the Lego family.
Valueact have repeatedly raised their holding, so it's not just me that sees something here.
He's now gone. His holding - and more - was picked up by Valueact, who just got Merlin Ent's in the UK sold into the Lego family.
Valueact have repeatedly raised their holding, so it's not just me that sees something here.
